Table 1. Demographic, clinicopathology, treatment characteristics of patients with GC.
| Variables | N (percentage) |
|---|---|
| Age | |
| <65 y | 37 (75.51%) |
| ≥65 y | 12 (24.49%) |
| Gender | |
| Male | 22 (44.90%) |
| Female | 27 (55.10%) |
| Marriage status | |
| Single | 1 (2.04%) |
| Married | 45 (91.84%) |
| Devoiced or widowed | 3 (6.12%) |
| Education level | |
| Elementary or below | 9 (18.37%) |
| Middle | 8 (16.33%) |
| High | 11 (22.45%) |
| College or above | 21 (42.86%) |
| Religion | |
| None | 42 (85.71%) |
| Buddhism | 7 (14.29%) |
| Preoperative BMI | |
| Underweight | 5 (10.20%) |
| Normal weight | 21 (42.86%) |
| Overweight | 10 (20.41%) |
| Obesity | 13 (26.53%) |
| Cancer stage | |
| II | 2 (4.08%) |
| III | 28 (57.14%) |
| IV | 19 (38.78%) |
| Cancer therapy | |
| Surgery | 1 (2.04%) |
| Surgery + Chemotherapy | 8 (16.33%) |
| Neoadjuvant chemotherapy +Surgery | 40 (81.63%) |
| Type of operation | |
| Distal | 25 (51.02%) |
| Total | 24 (48.98%) |
| Type of chemotherapy | |
| Base on paclitaxel | 37 (75.51%) |
| Base on xeloda | 1 (2.04%) |
| Base on oxaliplatin | 4 (8.16%) |
| Base on irinotecan | 1 (2.04%) |
| Base on S-1 | 6 (12.24%) |
| ONS | |
| Without | 28 (57.14%) |
| With | 21 (42.86%) |
| Complication | |
| Without | 36 (73.47%) |
| With | 13 (26.53%) |
Notes.
- BMI
- body mass index
- ONS
- oral nutritional supplements